Viekira Pak

Product NDC: 0074-3093
Requested package NDC: 0074-3093-01
11-digit product format: 000743093
Labeler code: 0074
Product ID: 0074-3093_d2f87bf8-2610-4486-940f-00f4f670e1bb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir
Dosage form: KIT
Labeler: AbbVie Inc.
Application: NDA206619
Marketing category: NDA
Marketing start: 2014-12-19
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0074-3093	0074-3093-01	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N206619-001	VIEKIRA PAK (COPACKAGED)	DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL		RLD	2014-12-19

Orange Book patents#

Current patent rows page 1 of 1 · 15 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N206619-001	9139536	2028-11-09	U-1753		2015-10-21
N206619-001	8501238	2028-12-19	U-1636	Drug substance, Drug product	2015-01-15
N206619-001	8188104	2029-05-17	U-1636	Drug substance, Drug product	2015-01-15
N206619-001	8642538	2029-09-10	U-1638	Drug substance, Drug product	2015-01-15
N206619-001	9006387	2030-06-10	U-1687		2015-05-06
N206619-001	8420596	2031-04-10		Drug substance, Drug product	2015-01-15
N206619-001	9044480	2031-04-10	U-1638		2015-07-01
N206619-001	8686026	2031-06-09		Drug product	2015-01-15
N206619-001	8691938	2032-04-13		Drug substance, Drug product	2015-01-15
N206619-001	8466159	2032-09-04	U-1637		2015-01-15
N206619-001	8492386	2032-09-04	U-1840		2015-01-15
N206619-001	8680106	2032-09-04	U-1637		2015-01-15
N206619-001	8685984	2032-09-04	U-1840		2015-01-15
N206619-001	10201542	2033-10-18	U-1753	Drug product	2019-03-14
N206619-001	9629841	2033-10-18	U-1753	Drug product	2017-06-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N206619-001	VIEKIRA PAK (COPACKAGED)	250.0MG;12.5MG;75.0MG;EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N206619-001	VIEKIRA PAK (COPACKAGED)	250.0MG;12.5MG;75.0MG;EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N206619-001	VIEKIRA PAK (COPACKAGED)	250.0MG;12.5MG;75.0MG;EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N206619-001	VIEKIRA PAK (COPACKAGED)	250.0MG;12.5MG;75.0MG;EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG	TABLET, TABLET / ORAL	RLD, RS	2014-12-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N206619-001	VIEKIRA PAK (COPACKAGED)	EQ 250MG BASE;12.5MG, 75MG, 50MG	TABLET / ORAL	RLD	2014-12-19	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 18 · 695 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N206619-001	9139536	2028-11-09	U-1753		2015-10-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8501238	2028-12-19	U-1636	Drug substance, Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8188104	2029-05-17	U-1636	Drug substance, Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8642538	2029-09-10	U-1638	Drug substance, Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	9006387	2030-06-10	U-1687		2015-05-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8420596	2031-04-10		Drug substance, Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	9044480	2031-04-10	U-1638		2015-07-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8686026	2031-06-09		Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8691938	2032-04-13		Drug substance, Drug product	2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8466159	2032-09-04	U-1637		2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8492386	2032-09-04	U-1840		2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8680106	2032-09-04	U-1637		2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	8685984	2032-09-04	U-1840		2015-01-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	10201542	2033-10-18	U-1753	Drug product	2019-03-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206619-001	9629841	2033-10-18	U-1753	Drug product	2017-06-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	9139536	2028-11-09	U-1753		2015-10-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8501238	2028-12-19	U-1636	Drug substance, Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8188104	2029-05-17	U-1636	Drug substance, Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8642538	2029-09-10	U-1638	Drug substance, Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	9006387	2030-06-10	U-1687		2015-05-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8420596	2031-04-10		Drug substance, Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	9044480	2031-04-10	U-1638		2015-07-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8686026	2031-06-09		Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8691938	2032-04-13		Drug substance, Drug product	2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8466159	2032-09-04	U-1637		2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8492386	2032-09-04	U-1840		2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8680106	2032-09-04	U-1637		2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	8685984	2032-09-04	U-1840		2015-01-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	10201542	2033-10-18	U-1753	Drug product	2019-03-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206619-001	9629841	2033-10-18	U-1753	Drug product	2017-06-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206619-001	9139536	2028-11-09	U-1753		2015-10-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8501238	2028-12-19	U-1636	Drug substance, Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8188104	2029-05-17	U-1636	Drug substance, Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8642538	2029-09-10	U-1638	Drug substance, Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	9006387	2030-06-10	U-1687		2015-05-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8420596	2031-04-10		Drug substance, Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	9044480	2031-04-10	U-1638		2015-07-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8686026	2031-06-09		Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8691938	2032-04-13		Drug substance, Drug product	2015-01-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206619-001	8466159	2032-09-04	U-1637		2015-01-15	`6a471c1ec25d…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N206619-001	D-163	2019-04-22	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N206619-001	NCE	2019-12-19	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N206619-001	D-163	2019-04-22	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N206619-001	NCE	2019-12-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206619-001	D-163	2019-04-22	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N206619-001	NCE	2019-12-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206619-001	D-163	2019-04-22	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N206619-001	NCE	2019-12-19	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0074-3093-28	EA - Each	0074-3093	7f3a0fd2-bef4-4a09-8af5-cfed692c9192	1	2015-01-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DASABUVIR SODIUM MONOHYDRATE	ACTIVE INGREDIENT	OG6D40M62L	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
OMBITASVIR HEMINONAHYDRATE	ACTIVE INGREDIENT	EQE3I70J3W	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
PARITAPREVIR DIHYDRATE	ACTIVE INGREDIENT	HRQ5901O78	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
RITONAVIR	ACTIVE INGREDIENT	O3J8G9O825	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
DASABUVIR	ACTIVE MOIETY	DE54EQW8T1	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
OMBITASVIR	ACTIVE MOIETY	2302768XJ8	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
PARITAPREVIR	ACTIVE MOIETY	OU2YM37K86	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
RITONAVIR	ACTIVE MOIETY	O3J8G9O825	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
COPOVIDONE K25-31	INACTIVE INGREDIENT	D9C330MD8B	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
POLYETHYLENE GLYCOL 3350	INACTIVE INGREDIENT	G2M7P15E5P	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
PROPYLENE GLYCOL LAURATES	INACTIVE INGREDIENT	40KT317HGP	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
SORBITAN MONOLAURATE	INACTIVE INGREDIENT	6W9PS8B71J	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203
TOCOPHERSOLAN	INACTIVE INGREDIENT	O03S90U1F2	VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]	203

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0074-3093-01	00074309301	1 DOSE PACK in 1 CARTON (0074-3093-01) > 1 KIT in 1 DOSE PACK	1 dose pack	2014-12-19	0000-00-00	No	No	Current